Chronic in-vivo studies through multimodal modulation of neurons in the deep brain can render pivotal insights not only in identifying their roles for a specific activity, but also to decipher their contribution in various neurodegenerative diseases. To prevent askew effects, probes were implanted to directly reach the target sites and the spatiotemporal resolution was further improved by targeting key neural circuits using optogenetics and pharmacology. Multimodal optofluidic probes allow integrated access to the target region without the need for multiple surgeries thus reducing tissue damage as well as simplifying combinatorial stimulations. Conventional tools have relied on rigid metal cannulas and silica optical fibers, but they cause adverse tissue inflammation due to their large probe sizes, rigid materials and associated tethers which severely limit their chronic integration. However, minimally invasive, mechanically compliant and untethered probes are shown to significantly limit tissue scarring in freely moving animals as shown in recent advances in soft optofluidic probes controlled by wireless head mounts, however, they didn’t last long primarily due to exhaustion of the drugs and power. Moreover, they were limited to the brain due to their bulky head mounts with limited range, directionality, and selectivity. Here we introduce two wireless optofluidic (wOF) neural devices each solving unique challenges faced by previous state-of-the-art devices and commercial pumps. Firstly, is the Lego wOF device which enables: 1) uninterrupted drug supply using replaceable “Lego” drug cartridges and 2) an easy-to-use smartphone app that allows long wireless range (~100m), isotropic wireless access, no Line of Sight (LOS) handicap, Over The Air (OTA) updates, high target specificity and scalable closed loop systems within a large group as well as intuitive control through an easy to use app on any commercial handheld smartphone. Second is the fully implantable wOF device which enables: 1) both central and peripheral stimulation in any space critical location inside the body (92% smaller and 88% lighter than previous systems), and 2) battery-free operation using a soft, stretchable energy harvester that can conformally adhere to any curvilinear surface inside the body. Successful in-vivo studies in mice demonstrate their innate capability for programmable and chronic wireless pharmacology and optogenetics.
|Advisor:||Jeong, Jae-Woong, Barnes, Frank|
|Commitee:||Le, Hanh-Phuc, Newman, Kimberly, Xiao, Jianliang|
|School:||University of Colorado at Boulder|
|School Location:||United States -- Colorado|
|Source:||DAI-B 80/09(E), Dissertation Abstracts International|
|Subjects:||Neurosciences, Engineering, Biomedical engineering|
|Keywords:||Drug delivery, Fully implantable, Neural device, Optogenetics, Smartphone controlled, Wireless optofluidics|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be